中国高血压患者心率管理多学科专家共识(2021年版)

2021-04-20 中国医学前沿杂志(电子版), 2021, 13(4): 38-48.

2017年我国发表《高血压患者心率管理中国专家共识》,专家们针对心率增快是否导致靶器官损害、如何界定心率增快等问题逐个进行讨论,提出了针对我国高血压患者心率管理的共识性建议。最近3年中,在心率检测技术

中文标题:

中国高血压患者心率管理多学科专家共识(2021年版)

发布机构:

发布日期:

2021-04-20

简要介绍:

2017年我国发表《高血压患者心率管理中国专家共识》,专家们针对心率增快是否导致靶器官损害、如何界定心率增快等问题逐个进行讨论,提出了针对我国高血压患者心率管理的共识性建议。最近3年中,在心率检测技术、心率增快机制以及心率增快的不利后果等方面均有较多新的、重要的研究结果发表,尤其是我国学者的大样本研究弥补了国内既往循证资料的不足。此外,越来越多的研究发现,心率增快的不利影响还涉及与高血压密切相关的多种内分泌、肾脏和神经内科疾病,心率管理需要多学科临床医生的参与。因此,我们决定撰写《中国高血压患者心率管理多学科专家共识(2021年版)》。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国高血压患者心率管理多学科专家共识_2021年版_施仲伟.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0e4721c0020983a7, title=中国高血压患者心率管理多学科专家共识(2021年版), enTitle=, guiderFrom=中国医学前沿杂志(电子版), 2021, 13(4): 38-48., authorId=0, author=, summary=2017年我国发表《高血压患者心率管理中国专家共识》,专家们针对心率增快是否导致靶器官损害、如何界定心率增快等问题逐个进行讨论,提出了针对我国高血压患者心率管理的共识性建议。最近3年中,在心率检测技术, cover=https://img.medsci.cn/2021516/1621128254572_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Apr 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2017年我国发表《高血压患者心率管理中国专家共识》,专家们针对心率增快是否导致靶器官损害、如何界定心率增快等问题逐个进行讨论,提出了针对我国高血压患者心率管理的共识性建议。最近3年中,在心率检测技术、心率增快机制以及心率增快的不利后果等方面均有较多新的、重要的研究结果发表,尤其是我国学者的大样本研究弥补了国内既往循证资料的不足。此外,越来越多的研究发现,心率增快的不利影响还涉及与高血压密切相关的多种内分泌、肾脏和神经内科疾病,心率管理需要多学科临床医生的参与。因此,我们决定撰写《中国高血压患者心率管理多学科专家共识(2021年版)》。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=274, tagName=高血压), TagDto(tagId=20817, tagName=心率管理)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=274, guiderKeyword=高血压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2659, appHits=280, showAppHits=0, pcHits=558, showPcHits=2379, likes=3, shares=28, comments=13, approvalStatus=1, publishedTime=Sun May 16 09:44:14 CST 2021, publishedTimeString=2021-04-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun May 16 09:28:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:41:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国高血压患者心率管理多学科专家共识_2021年版_施仲伟.pdf)])
中国高血压患者心率管理多学科专家共识_2021年版_施仲伟.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1199189, encodeId=1bec11991894d, content=很好,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f536476893, createdName=ms5000001743524586, createdTime=Thu Mar 03 21:17:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084072, encodeId=bbfe10840e22b, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:20:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084076, encodeId=f5c610840e6e5, content=学习了 高血压控制心率也非常重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:27:19 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067782, encodeId=6c1d106e782fb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c45695905, createdName=ms9000001117153275, createdTime=Sun Nov 07 13:28:22 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067598, encodeId=87d8106e59841, content=好复杂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Sat Nov 06 15:41:00 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2022-03-03 ms5000001743524586

    很好,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1199189, encodeId=1bec11991894d, content=很好,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f536476893, createdName=ms5000001743524586, createdTime=Thu Mar 03 21:17:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084072, encodeId=bbfe10840e22b, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:20:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084076, encodeId=f5c610840e6e5, content=学习了 高血压控制心率也非常重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:27:19 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067782, encodeId=6c1d106e782fb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c45695905, createdName=ms9000001117153275, createdTime=Sun Nov 07 13:28:22 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067598, encodeId=87d8106e59841, content=好复杂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Sat Nov 06 15:41:00 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-12-24 ms9000001909452692

    学习了谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1199189, encodeId=1bec11991894d, content=很好,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f536476893, createdName=ms5000001743524586, createdTime=Thu Mar 03 21:17:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084072, encodeId=bbfe10840e22b, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:20:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084076, encodeId=f5c610840e6e5, content=学习了 高血压控制心率也非常重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:27:19 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067782, encodeId=6c1d106e782fb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c45695905, createdName=ms9000001117153275, createdTime=Sun Nov 07 13:28:22 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067598, encodeId=87d8106e59841, content=好复杂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Sat Nov 06 15:41:00 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-12-24 ms9000001909452692

    学习了 高血压控制心率也非常重要

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1199189, encodeId=1bec11991894d, content=很好,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f536476893, createdName=ms5000001743524586, createdTime=Thu Mar 03 21:17:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084072, encodeId=bbfe10840e22b, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:20:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084076, encodeId=f5c610840e6e5, content=学习了 高血压控制心率也非常重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:27:19 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067782, encodeId=6c1d106e782fb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c45695905, createdName=ms9000001117153275, createdTime=Sun Nov 07 13:28:22 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067598, encodeId=87d8106e59841, content=好复杂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Sat Nov 06 15:41:00 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-11-07 ms9000001117153275

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1199189, encodeId=1bec11991894d, content=很好,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f536476893, createdName=ms5000001743524586, createdTime=Thu Mar 03 21:17:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084072, encodeId=bbfe10840e22b, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:20:56 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084076, encodeId=f5c610840e6e5, content=学习了 高血压控制心率也非常重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca0a5567494, createdName=ms9000001909452692, createdTime=Fri Dec 24 22:27:19 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067782, encodeId=6c1d106e782fb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c45695905, createdName=ms9000001117153275, createdTime=Sun Nov 07 13:28:22 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067598, encodeId=87d8106e59841, content=好复杂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/8cccaba4e37b47ca8e152a4f732847fb/0d1d2c7e0bd7426b9ecd3318c9f11128.jpg, createdBy=14492036103, createdName=木马🎠, createdTime=Sat Nov 06 15:41:00 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-11-06 木马🎠

    好复杂

    0

拓展阅读

2009ESH 欧洲高血压指南重新评估

欧洲高血压学会(ESH,European Society of Hypertension) · 2009-11-01

2010 台湾高血压管理指南(英文版)

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2010-01-01

2010年中国肺高血压诊治指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

2010高血压患者胆固醇管理临床指导建议

中国心血管相关专家小组(统称) · 2010-02-01

2009年基层版《中国高血压防治指南》

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-02-10

2010 中国急诊高血压管理专家共识

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2010-03-19